Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

3-Epideoxycholic acid is a secondary bile acid formed via epimerization of deoxycholic acid (DCA; Item Nos. 20756 | 18231) by gut microbiota.1 It has reduced detergent activity and is less active than DCA in inhibiting growth in a panel of seven gut bacteria species. 3-Epideoxycholic acid (10 and 20 µM) increases the growth of Caco-2 colon cancer cells but to a lesser extent than DCA.2 It increases the levels of Foxp3+CD4+ regulatory T cells (Tregs) in a co-culture of naïve T cells and dendritic cells.3
WARNING This product is not for human or veterinary use.
1. A biosynthetic pathway for a prominent class of microbiota-
2. Effects of deoxycholate on human colon cancer cells: Apoptosis or proliferation. Eur. J. Clin. Invest. 32(1), 29-34 (2002).
3. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature 58(7809), 475-479 (2020).